PMID- 37127791 OWN - NLM STAT- MEDLINE DCOM- 20230503 LR - 20230510 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 13 IP - 1 DP - 2023 May 1 TI - The interplay between bicarbonate kinetics and gastrointestinal upset on ergogenic potential after sodium bicarbonate intake: a randomized double-blind placebo-controlled trial. PG - 7081 LID - 10.1038/s41598-023-34343-0 [doi] LID - 7081 AB - This double-blind placebo-controlled cross-over study utilized comprehensive monitoring of blood bicarbonate (HCO(3)( )) kinetics and evaluation of gastrointestinal (GI) upset to determine their impact on an ergogenic potential of sodium bicarbonate (SB) co-ingested with carbohydrate (CHO). Nineteen CrossFit athletes performed 6 bouts of 15 s Wingate Anaerobic Test (WAnT) 90 min post-ingestion of 0.4 g.kg(-1) body mass (BM) of SB (SB + CHO treatment) or PLA (PLA + CHO treatment) with 15 g CHO. Blood HCO(3)( ) concentration was evaluated at baseline, 30-, 60-, 75- and 90 min post-ingestion, in between WAnT bouts, and 3 and 45 min post-exercise, while GI upset at 120 min after protocol started. Control (no supplementation; CTRL) procedures were also performed. An effective elevation of extra-cellular buffering capacity was observed 60-90 min post-ingestion of SB + CHO. At mean peak blood HCO(3)( ), or at start of exercise an increase > 6 mmol.L(-1) in HCO(3)( ) was noted in 84% and 52.6% participants, respectively. SB + CHO did not prevent performance decrements in WAnT bouts. There were no significant relationships between changes in blood HCO(3)( ) and WAnTs' performance. Total GI was significantly higher in SB + CHO compared to CTRL, and stomach problems in SB + CHO compared to CTRL and PLA + CHO. There were inverse associations between peak- (p = 0.031; r = - 0.495), average- (p = 0.002; r = - 0.674) and minimum power (p = 0.008; r = - 0.585) and total GI upset, as well as average power and severe GI distress (p = 0.042; r = - 0.471) at SB + CHO. The implemented dose of SB + CHO was effective in improving buffering capacity, but did not prevent decrements in WAnTs' performance. GI side effects were crucial in affecting the ergogenic potential of SB and thus must be insightfully monitored in future studies. CI - (c) 2023. The Author(s). FAU - Durkalec-Michalski, Krzysztof AU - Durkalec-Michalski K AD - Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland. durkalec-michalski@awf.poznan.pl. AD - Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic. durkalec-michalski@awf.poznan.pl. FAU - Nowaczyk, Paulina M AU - Nowaczyk PM AD - Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland. FAU - Kaminska, Joanna AU - Kaminska J AD - Department of Physiology and Biochemistry, Poznan University of Physical Education, Poznan, Poland. FAU - Saunders, Bryan AU - Saunders B AD - Applied Physiology and Nutrition Research Group, School of Physical Education and Sport, Rheumatology Division, Faculdade de Medicina FMUSP, University of Sao Paulo, Sao Paulo, Brazil. AD - Institute of Orthopedics and Traumatology, Faculty of Medicine FMUSP, University of Sao Paulo, Sao Paulo, Brazil. FAU - Loniewski, Igor AU - Loniewski I AD - Department of Biochemical Sciences, Pomeranian Medical University in Szczecin, Szczecin, Poland. FAU - Czubaszek, Dominika AU - Czubaszek D AD - Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland. FAU - Steffl, Michal AU - Steffl M AD - Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic. FAU - Podgorski, Tomasz AU - Podgorski T AD - Department of Physiology and Biochemistry, Poznan University of Physical Education, Poznan, Poland. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20230501 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 8MDF5V39QO (Sodium Bicarbonate) RN - 0 (Bicarbonates) RN - 0 (Polyesters) SB - IM MH - Humans MH - Sodium Bicarbonate/adverse effects MH - Bicarbonates MH - Cross-Over Studies MH - *Gastrointestinal Diseases/chemically induced MH - Polyesters MH - Double-Blind Method MH - *Athletic Performance PMC - PMC10151363 COIS- I.L. is a shareholder of an alkali products distributor and has received honoraria from the Sanum Polska sp. z o. o. However, the content of this study was not constrained by this fact in absolutely no extend. K.D.-M., P.M.N., J.K., B.S., D.C., M.S., and T.P. report no conflicts of interest. The results of the present study do not constitute endorsement by the Scientific Reports. The authors declare that the results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. EDAT- 2023/05/02 00:42 MHDA- 2023/05/03 06:42 PMCR- 2023/05/01 CRDT- 2023/05/01 23:26 PHST- 2023/02/04 00:00 [received] PHST- 2023/04/27 00:00 [accepted] PHST- 2023/05/03 06:42 [medline] PHST- 2023/05/02 00:42 [pubmed] PHST- 2023/05/01 23:26 [entrez] PHST- 2023/05/01 00:00 [pmc-release] AID - 10.1038/s41598-023-34343-0 [pii] AID - 34343 [pii] AID - 10.1038/s41598-023-34343-0 [doi] PST - epublish SO - Sci Rep. 2023 May 1;13(1):7081. doi: 10.1038/s41598-023-34343-0.